Insight Molecular Diagnostics: Q3 Earnings Snapshot

Detailed summary
NASHVILLE, Tenn. (AP) — NASHVILLE, Tenn. (AP) — Insight Molecular Diagnostics Inc. (IMDX) on Monday reported a loss of $3.6 million in its third quarter. On a per-share basis, the…
NASHVILLE, Tenn. (AP) — NASHVILLE, Tenn. (AP) — Insight Molecular Diagnostics Inc. (IMDX) on Monday reported a loss of $3.6 million in its third quarter.
On a per-share basis, the Nashville, Tennessee-based company said it had a loss of 10 cents. Losses, adjusted for non-recurring gains, came to 19 cents per share.
The cancer diagnostic test developer posted revenue of $559,000 in the period.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IMDX at https://www.zacks.com/ap/IMDX
Opening of the article, excerpted from Yahoo Finance. To read the rest, open the article on the publisher's site.
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finance.yahoo.com)




